LAUREN KASHA SMITH: Open Payments
NPI 1952079303 · EVANSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,507 in 71 payments from 11 companies in 2025. Trend: 2023 $1,221 · 2024 $890 · 2025 $1,507
Food & beverage: $1,435Education: $72
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 20 | $383 |
| UCB, Inc. | 17 | $340 |
| Lilly USA, LLC | 5 | $192 |
| E.R. Squibb & Sons, L.L.C. | 10 | $179 |
| ABBVIE INC. | 5 | $107 |
| Novartis Pharmaceuticals Corporation | 4 | $78 |
| Regeneron Healthcare Solutions, Inc. | 3 | $66 |
| Amgen Inc. | 3 | $59 |
| Galderma Laboratories, L.P. | 1 | $53 |
| GENZYME CORPORATION | 2 | $35 |
Products named: TREMFYA, Bimzelx, Sotyktu, EBGLYSS, DUPIXENT, RINVOQ, COSENTYX, TALTZ.
Industry payments across IN — which companies pay providers there.
